SCHEMBL4774088

SCHEMBL4774088

CC(Cc1nc2c(nc(-c3ccc(Cl)cc3)n2CC(F)(F)F)c(=O)[nH]1)CC(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
PDE9A O76083 3/20 0.35
PDE1C Q14123 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
METAP2 P50579 7/20 0.34
DHFR P00374 1/20 0.34
PDE2A O00408 2/20 0.32
KDM5A P29375 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776027 0.90 HPGD (0.35) CNR1KDM4EALDH1A1PKMHPGD
SCHEMBL4290740 0.88 MEN1 (0.42) KDM4EALDH1A1PKMHPGDPDE9A
SCHEMBL4774180 0.85 AVPR2 (0.37) KDM4EALDH1A1PKMHPGDPDE9A
SCHEMBL4292483 0.83 PDE9A (0.36) CNR1KDM4EALDH1A1PKMHPGD
SCHEMBL4766933 0.80 KDM4E (0.39) CNR1KDM4EALDH1A1PKMHPGD
SCHEMBL4290620 0.78 PDE9A (0.45) KDM4EALDH1A1PKMHPGDPDE9A
SCHEMBL4296187 0.76 PDE9A (0.48) KDM4EALDH1A1PKMHPGDPDE9A
SCHEMBL4297801 0.76 PDE9A (0.48) KDM4EALDH1A1PKMHPGDPDE9A
SCHEMBL4290696 0.74 ALDH1A1 (0.38) KDM4EALDH1A1PKMHPGDPDE9A
SCHEMBL4619749 0.74 METAP2 (0.36) CNR1KDM4EALDH1A1PKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed